Kestra Private Wealth Services LLC Sells 1,372 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Kestra Private Wealth Services LLC trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 20.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,441 shares of the financial services provider’s stock after selling 1,372 shares during the period. Kestra Private Wealth Services LLC’s holdings in iShares Biotechnology ETF were worth $739,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Glass Jacobson Investment Advisors llc increased its stake in iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares in the last quarter. Values First Advisors Inc. bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at approximately $43,000. Tennessee Valley Asset Management Partners bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at approximately $44,000. Column Capital Advisors LLC bought a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $49,000. Finally, Massmutual Trust Co. FSB ADV increased its stake in iShares Biotechnology ETF by 164.2% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 225 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of NASDAQ:IBB opened at $132.96 on Friday. The company has a 50 day moving average price of $133.61 and a two-hundred day moving average price of $130.05. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.38%.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBFree Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.